Latest News & Features
Americas
A former Johnson & Johnson IP counsel and a retired judge are among the speakers at Life Sciences IP Due Diligence, on November 29 and 30 in Boston, as LSIPR finds out. 10 October 2018
Americas
North Carolina-based Duke University and Allergan have brought their patent dispute with medical company Alcon Laboratories to an end in Delaware. 9 October 2018
Americas
The IP concessions in the United States-Mexico-Canada Agreement are the latest hit for access to affordable prescription medicines for Canadians, according to the Canadian Generic Pharmaceutical Association. 9 October 2018
Americas
The US International Trade Commission has voted to begin an investigation into US medical device maker ResMed following a complaint from New Zealand-based rival Fisher & Paykel Healthcare. 8 October 2018
Americas
US-based law firm O’Melveny has hired Hassen Sayeed as a partner in its IP and technology practice group in New York. 8 October 2018
Biotechnology
Depending on the facts and the content of the applications, an Arrow-type declaration could be made on grounds of insufficiency against divisional applications, say David Holt and Tony Proctor of Potter Clarkson. 8 October 2018
Americas
The Patent Trial and Appeal Board invalidated a patent owned by biotech company Biogen yesterday, handing a victory to South Korea-based Celltrion. 5 October 2018
Americas
Janssen, a subsidiary of Johnson & Johnson, has entered into a licence and collaboration agreement with drug maker Arrowhead Pharmaceuticals. 5 October 2018
Big Pharma
The UK’s Medicines and Healthcare Products Regulatory Agency is seeking industry views on a no-deal Brexit scenario. 4 October 2018
Americas
Boston Pharmaceuticals yesterday signed deals with GSK and Novartis, licensing eight drug candidates in total. 4 October 2018